Wednesday, February 18, 2026 2/18/2026

Unveiling how the molecular landscape of TNBC sculps intratumoral macrophage origin and function

Award Number: F31CA281063
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2026

Group Awards By:

View Award Description

Unveiling how the molecular landscape of TNBC sculps intratumoral macrophage origin and function - ABSTRACT/PROJECT SUMMARY. Triple-negative breast cancer (TNBC) is a heterogenous set of diseases and is considered one of the most aggressive breast cancer subtypes. TNBC lack of well-defined endocrine markers limits the therapeutic options for these patients. This has spurred significant efforts towards developing therapies directed towards the tumor microenvironment, but these have demonstrated only modest success. This is attributed to the high functional heterogeneity of macrophages, which is in part determined by their origin, and the distinct molecular landscape of different TNBC subtypes. Our overarching objective is to elucidate a link between the molecular profile of TNBC and macrophage origin and function in order to establish the groundwork for the finetuning of the next generation of macrophage-targeted therapies to consider the tumor's molecular signature as a proxy for macrophage function. The overall objective of this proposal is to examine a potential enrichment of macrophages from different origins and functional profiles in TNBC subtypes with divergent molecular landscapes. The central hypothesis is that luminal TNBC subtypes are enriched for tumor antagonistic TRMs and their ablation gives way to pro-tumor MDMs colonization. The rationale is that intratumoral macrophages can stem from different origins (i.e., embryonically derived tissue-resident (TRMs) or monocyte-derived (MDMs)), which strongly influence their functional profile. MDMs are associated with tumor promoting properties, while TRMs have been reported to play tumor antagonistic roles. Our preliminary data supports that TNBC with divergent molecular profiles are enriched for macrophages of divergent origins. This proposal consists of proof-of-principle studies to demonstrate macrophages TNBC molecular subtypes that preserve epithelial properties are enriched for tumor antagonistic TRMs, while TNBC molecular subtypes that have acquired mesenchymal features are enriched for tumor-promoting MDMs. Along this trajectory, the central hypothesis will be tested by pursuing two specific aims. Aim 1 will determine the origin and function of intratumoral macrophages in claudin-low and luminal-like TNBC tumor subtypes and the need for epithelial features to main a TRM pool. Aim 2 will determine a skewing of the macrophage compartment towards pro- tumor MDMs in luminal-like TNBC after cessation of macrophage-ablation therapy. The proposed studies are innovative because they will establish a correlation between TNBC molecular profile and macrophage origin and function. The project is significant because establishing the molecular landscape of TNBC as a proxy for macrophage function will serve to tailor macrophage-targeted therapies to account for macrophage heterogeneity.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $49,538 )
2025	2025	BAYLOR COLLEGE OF MEDICINE	1 BAYLOR PLZ	HOUSTON	TX	77030	HARRIS	USA	Cancer Research Manpower	000	2	7/16/2025	NON-COMPETING CONTINUATION	$49,538
														Subtotal = $49,538

Issue Date FY: 2024 ( Subtotal = $51,974 )
2024	2024	BAYLOR COLLEGE OF MEDICINE	1 BAYLOR PLZ	HOUSTON	TX	77030	HARRIS	USA	Cancer Research Manpower	000	1	3/28/2024	NEW	$50,194
2024	2024	BAYLOR COLLEGE OF MEDICINE	1 BAYLOR PLZ	HOUSTON	TX	77030	HARRIS	USA	Cancer Research Manpower	001	1	5/8/2024	NEW	$1,780
2024	2024	BAYLOR COLLEGE OF MEDICINE	1 BAYLOR PLZ	HOUSTON	TX	77030	HARRIS	USA	Cancer Research Manpower	002	1	5/8/2024	NEW	$0
														Subtotal = $51,974

Grand Total All Awards = $101,512

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Unveiling how the molecular landscape of TNBC sculps intratumoral macrophage origin and function

Award Number: F31CA281063

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer